Basic Information
ID: ALA4825212
Type: Binding
Description: Inhibition of recombinant SARS-CoV-2 main protease using Dabcyl-KTSAVLQ-SGFRKM-E(Edans-NH2) as substrate preincubated for 15 mins followed by substrate addition by FRET based assay
Format: BAO_0000019
Organism: Severe acute respiratory syndrome coronavirus 2
Target: Unchecked(ALA612545)
Document: ALA4823308
Inhibition of recombinant SARS-CoV-2 main protease using Dabcyl-KTSAVLQ-SGFRKM-E(Edans-NH2) as substrate preincubated for 15 mins followed by substrate addition by FRET based assay: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4825212
IC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 349.39 | 4.44 | 4.44 |
| 464.91 | 3.26 | 3.26 |
| 441.92 | 5.88 | 5.88 |
| 495.89 | 6.42 | 6.42 |
| 453.93 | 5.88 | 5.88 |
| 565.39 | 4.98 | 4.98 |
| 503.90 | 3.47 | 3.47 |
| 587.97 | 4.66 | 4.66 |
| 504.85 | 3.93 | 3.93 |
| 519.97 | 3.94 | 3.94 |
| 481.98 | 6.66 | 6.66 |
| 551.36 | 4.97 | 4.97 |
| 494.94 | 5.97 | 5.97 |
| 476.92 | 3.40 | 3.40 |
| 571.90 | 4.19 | 4.19 |
| 450.88 | 3.39 | 3.39 |
| 518.88 | 3.94 | 3.94 |
| 573.94 | 4.65 | 4.65 |
| 557.87 | 4.18 | 4.18 |
| 503.90 | 3.47 | 3.47 |
| 539.40 | 4.89 | 4.89 |